1. Public Home Page
  2. Patient resources
  3. Tafinlar + Mekinist patient resources: for metastatic melanoma patients

This page is specifically intended to support patients who have been prescribed Tafinlar + Mekinist by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

 

Tafinlar + Mekinist patient resources: for metastatic melanoma patients

Introduction

 

What is Melanoma?

 
 

What is BRAF V600 positive metastatic melanoma?

 

What are Tafinlar and Mekinist?

 
 

How to take Tafinlar and Mekinist

 

Side effects

 
 

Further information and support

 
 
 

Filmed: September 2018 | TMC17-C045(1)a(1) | August 2020

 

References:

  1. Cancer Research UK. What is melanoma? Available at: https://www.cancerresearchuk.org/about-cancer/melanoma/about [Last Accessed: January 2022]
  2. Cancer Research UK. Types. Available at: https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/types [Last Accessed: January 2022]
  3. Cancer Research UK. Stages and types. Available at: https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types [Last Accessed: January 2022]
  4. Tafinlar Package leaflet: Information for the patient. Available at: https://www.medicines.org.uk/emc/files/pil.7837.pdf [Last Accessed: January 2022]
  5. Mekinist Package leaflet: Information for the patient. Available at: https://www.medicines.org.uk/emc/files/pil.5072.pdf [Last Accessed: January 2022]
  6. Cancer Research UK. Genetic tests on your melanoma cells. Available at: https://www.cancerresearchuk.org/about-cancer/melanoma/getting-diagnosed... [Last Accessed: January 2022]
Rate this content: 
No votes yet
UK | January 2022 | 184172
Oncology
Article
×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.